Dr. Catherine holds over 18 years of post-doctoral experience in therapeutic discovery, with strategic roles in biotechnology, consultancy, and CRO organizations. She has contributed to small molecule therapeutics, peptides, health tech, and engineering. She started her career at Isogenica and Bicycle Therapeutics, establishing therapeutic platforms and discovery programs. She has also consulted for various biotech and health tech start-ups to develop platform technologies at the intersection of biology and engineering. Before joining o2h, she was EVP of Business Development at Domainex, collaborating with companies in the UK, USA, and Europe.

She has completed an MSc in Biochemistry from Nottingham, a PhD in Cell Biology from Cambridge, and an MBA from the Open University.